Home›Search›Blood Cancer Journal

Blood Cancer Journal

Springer Nature · United Kingdom · Est. 1987

ISSN2044-5385eISSN2044-5385

SJR Q1✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access

100

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (4 more)+22

Total100

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

110

days submission → published

measured · last 20 articles · accept 96d

weeks to publish · journal-reported

Average · vs ~15 wk median

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

4.307

H-Indexi

106

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

2.851

Total Worksi

2,096

Total Citationsi

67,193

2yr Mean Citednessi

6.69

Open Impact Factor alternative

Aims & Scope

Blood Cancer Journal seeks to publish articles of the highest quality related to hematologic malignancies and related disorders. The Journal will consider for publication original research, reviews, guidelines and letters that are considered to be of high impact in the field. Topics of particular interest include, but are not limited to, the following: Preclinical studies of new compounds, especially those that provide mechanistic insights Clinical trials and observations Reviews related to new drugs and current management of hematologic malignancies Novel observations related to new mutations, molecular pathways, and tumor genomics Blood Cancer Journal offers a forum for expedited publication of novel observations regarding new mutations or altered pathways.

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1987

FrequencyIrregular

StatusActive (last: 2026)

Total Publications2,096

Publisher OrgSpringer Nature

OA Since2010

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

Review Time~14 weeks

Acceptance Rate—

OA LicenseCC BY, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

9/12 · 75%

✅

Do you know the journal / publisher?

Springer Nature

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2044-5385 / 2044-5385

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

103

2019

126

2020

203

11k

2021

173

4.7k

2022

194

3.9k

2023

224

3.2k

2024

229

905

2025

118

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

HematologyQ1

OncologyQ1

Subject Classification

Web of Science Categories

HematologyOncology

Scopus Categories

HematologyOncology

Research Topics (OpenAlex)

Multiple Myeloma Research and TreatmentsAcute Myeloid Leukemia ResearchLymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchMyeloproliferative Neoplasms: Diagnosis and TreatmentProtein Degradation and InhibitorsChronic Myeloid Leukemia TreatmentsAcute Lymphoblastic Leukemia researchCAR-T cell therapy researchHematopoietic Stem Cell Transplantation

Frequently asked questions about Blood Cancer Journal

Is Blood Cancer Journal a predatory journal?

PubScope has no integrity flags on record for Blood Cancer Journal: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Blood Cancer Journal?

Blood Cancer Journal is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 6.69.

Is Blood Cancer Journal indexed in Scopus and Web of Science?

Blood Cancer Journal is indexed in Web of Science, Scopus, DOAJ.